Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC/CDK2/DNMT1 pathway

  1. Wan-cheng Liu
  2. Yi-hong Wei
  3. Jin-feng Chen
  4. Xiang-ling Xing
  5. He-xiao Jia
  6. Xin-yu Yang
  7. Ying-jian Huang
  8. Xiao-min Liu
  9. Ke Xiao
  10. Xiao-dong Guo
  11. Can Can
  12. A-min Zhang
  13. Na He
  14. Hai-lei Zhang
  15. Dao-xin Ma
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1038/s41467-025-60293-4
  2. Version published to 10.21203/rs.3.rs-4352052/v1 on Research Square